More search options
Basket icon
No items
Basket icon

Search results

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
We have found 20 products that meet your criteria.
New search Share these results
You searched using the following criteria:
Specific topic: Big Pharma
Too few results? Show fuzzy matches 

Too many results?

Refine search
Alternatively, use the filters below to quickly narrow your search and identify items of further interest.
Not yet registered with us?

Register today to place orders, create search alerts, submit cases to us ... and much more.

Registered educators and trainers, and their support staff, can also access preview copies, instructor materials and see product reviews and usage.

Find out what you’re missing 

Applying filter...
Case
-
Reference no. 310-140-1
Subject category: Strategy and General Management
Authors: Sushree Das (Amity Research Centers)
Published by: Amity Research Centers
Published in: 2010
Length: 11 pages
Data source: Published sources
Topics: Dr Reddy's; Pharma sector; Rural markets; Branded generics; Betapharm; GSK; India; USA; Big Pharma; Clinical research; Acquisition; Outsourcing; Brand portfolio; Active ingredients; Global pharma hub
View full details
Share a link: https://casecent.re/p/95420
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Case
-
Reference no. 204-024-1
Subject category: Economics, Politics and Business Environment
Authors: N Rajshekar (IBS Case Development Center); BN Renuka Prasad (IBS Case Development Center)
Published by: IBS Case Development Center
Published in: 2004
Length: 10 pages
Data source: Published sources
Topics: Big Pharma; R&D; Pfizer; Novartis; New molecular entities; Eli Lilly; AstraZeneca; Bristol-Myers Squibb; Sanofi-Synthelabo; Schering-Plough; Merck; Pharmaceutical; GlaxoSmithKline; USFDA; Drugs
View full details
Share a link: https://casecent.re/p/19486
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Case
-
Reference no. 304-113-1
Subject category: Strategy and General Management
Authors: N Rajshekar (IBS Case Development Center); BN Renuka Prasad (IBS Case Development Center)
Published by: IBS Case Development Center
Published in: 2004
Length: 7 pages
Data source: Published sources
Topics: Nicholas Piramal India Limited; Ajay Piramal; Joint venture; Mergers & acquisitions (M&A); Research and development (R&D); Growth strategy; Indian pharmaceutical industry; Blockbuster drugs; GlaxoSmithKline; Rhone Poulenc; Generic competition; Big Pharma; Patents and patented drugs; Food and drug administration (FDA); 1970 Indian Patent Act
View full details
Share a link: https://casecent.re/p/19722
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Case
-
Reference no. 304-224-1
Subject category: Strategy and General Management
Authors: G Srikanth (IBS Case Development Center); BN Renuka Prasad (IBS Case Development Center)
Published by: IBS Case Development Center
Published in: 2004
Length: 8 pages
Data source: Published sources
Topics: Genentech; Business strategy; Biotechnology industry; Research and development (R&D); United States pharmaceutical industry; Avastin; Arthur D Levinson; Big Pharma; Targeted therapies; Rituxan; Herceptin; Food and Drug Administration; United States Food and Drug Administration; Blockbuster drugs; Biologics license application
View full details
Share a link: https://casecent.re/p/19802
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Compact case
Case
-
Reference no. 305-281-1
Subject category: Strategy and General Management
Authors: Sumit Kumar Chaudhuri (IBS Case Development Center); Saradhi Kumar Gonela (IBS Case Development Center)
Published by: IBS Case Development Center
Published in: 2005
Length: 5 pages
Data source: Published sources
Topics: Global pharmaceutical industry; Business model of drug companies; Drug industry; Big Pharma; Innovation in pharmaceuticals; Drug marketing; Advertising for drugs; Blockbuster drugs; Patent laws for drugs; Cost components of drug companies; Research and development in drug companies
View full details
Share a link: https://casecent.re/p/63498
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Case
-
Reference no. 305-596-1
Subject category: Strategy and General Management
Authors: Supratim Majumdar (IBS Research Centre, Kolkata (IRCK)); Abhishek Roy Chowdhury (IBS Research Centre, Kolkata (IRCK))
Published by: IBS Research Center
Published in: 2005
Length: 19 pages
Data source: Published sources
Topics: Novartis; Sandoz; Hexal AG; Eon Labs; Pharmaceutical (pharma) industry; Generic drugs; Patented drugs; Acquisition; Intellectual property rights; Blockbuster drug; Big Pharma; Cost competitiveness; Extended product portfolio; Vertical integration; Daniel Vasella
View full details
Share a link: https://casecent.re/p/66116
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Case
-
Reference no. UVA-OM-1775
Subject category: Production and Operations Management
Authors: Panos Markou (Darden School of Business, University of Virginia); Yael Grushka-Cockayne (Darden School of Business, University of Virginia); Raul O Chao (Darden School of Business, University of Virginia); Joshua Hattem (Darden School of Business, University of Virginia)
Published by: Darden Business Publishing
Originally published in: 2022
Version: 2 July 2024
Revision date: 25-Jul-2024
Length: 16 pages
Data source: Field research
Topics: Innovation; R&D; Project selection; Project portfolio decision-making; Bottom-up selection; Top-down selection; Market risk; Technology risk; Uncertainty; Pharmaceutical industry; Pharma; Big Pharma; Drug development; Cancer; Oncology
View full details
Share a link: https://casecent.re/p/186250
| No reviews for this item
View our pricing guide or login to see prices.
Case
-
Reference no. 315-154-1
Subject category: Strategy and General Management
Authors: Rika Misra (Amity Research Centers); Azmal Hussain (Amity Research Centers)
Published by: Amity Research Centers
Published in: 2015
Length: 8 pages
Data source: Published sources
Topics: Sun Pharmaceutical Industries Ltd; Technion - Israel Institute of Technology; Sun Pharma-Technion pact; Clinical trial databases; Pharma-academia collaborations; Patent protection; National Institutes of Health; Anti-cancer drugs; Big Pharma; Industry-academia collaboration; Pharma-Academia Partnership Models
View full details
Share a link: https://casecent.re/p/128535
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Case
-
Reference no. 113-021-1
Subject category: Finance, Accounting and Control
Authors: Wouter De Maeseneire (Vlerick Business School); Jonas Standaert (Vlerick Business School)
Published by: Vlerick Business School
Published in: 2013
Length: 21 pages
Data source: Published sources
Topics: Financial statements; Financial statement analysis; Big Pharma; Biotechnology; Business model; Liquidity; Profitability; Solvency; Balance sheet; P&L; Income statement; Cash flow statement; Cash flow analysis; Ratio analysis; Financial performance
View full details
Share a link: https://casecent.re/p/114668
| No reviews for this item
View our pricing guide or login to see prices.
Case
-
Reference no. 313-146-1
Subject category: Strategy and General Management
Authors: Sushree Das (Amity Research Centers)
Published by: Amity Research Centers
Published in: 2013
Length: 11 pages
Data source: Published sources
Topics: Pharma; Novartis; Glivec; USA; Patent; Anti-cancer; Imatinib Mesylate; Ranbaxy; CIPLA; Natco Pharma; License; Supreme Court of India; Big Pharma; Legal; India
View full details
Share a link: https://casecent.re/p/116099
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Case
-
Reference no. SMU-13-0015
Subject category: Marketing
Authors: Srinivas K Reddy (Singapore Management University); David Llewelyn (Singapore Management University); Sarita Mathur (Singapore Management University)
Published by: Singapore Management University
Originally published in: 2013
Version: 2015-10-13
Revision date: 11-Nov-2015
Length: 30 pages
Data source: Published sources
Topics: Pharmaceuticals; Intellectual property (IP); Emerging markets; Novartis; Glivek; Drugs; Business models; Ethics; Patenting; Big Pharma; Business model adaptation; Pricing; Pricing strategies
View full details
Share a link: https://casecent.re/p/117899
| No reviews for this item
View our pricing guide or login to see prices.
Case
-
Reference no. UVA-F-2028
Subject category: Finance, Accounting and Control
Authors: Michael J Schill (Darden School of Business, University of Virginia); Adam Yates (Darden School of Business, University of Virginia)
Published by: Darden Business Publishing
Originally published in: 2023
Version: 31 October 2024
Revision date: 19-Nov-2024
Length: 18 pages
Data source: Published sources
Topics: Teva; Pharmaceuticals; Big Pharma; Multicurrency bond; Generic drug; Bond issue; M&A; Acquisition; Cross-border acquisition; Risk premium; Risk-return paradigm; Risk-free rate; Cost of debt; Default risk; Credit rating
View full details
Share a link: https://casecent.re/p/192991
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Technical note
-
Reference no. UVA-OM-1796
Subject category: Production and Operations Management
Authors: Gaynell Paul Matherne (Darden School of Business, University of Virginia); Christoph Herpfer (Darden School of Business, University of Virginia); Ethan Dow (Darden School of Business, University of Virginia)
Published by: Darden Business Publishing
Originally published in: 2023
Version: 29 May 2024
Revision date: 4-Jun-2024
Length: 8 pages
Data source: Published sources
Topics: Biotechnology; Biotech; Pharmaceutical; Pharma; Big Pharma; Drug development; FDA; Food and Drug Administration; Biologic; Venture capital; VC; M&A; R&D; Clinical trial; Hatch-Waxman
View full details
Share a link: https://casecent.re/p/195334
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
New product
Case
-
Reference no. UVA-GEM-0235
Subject category: Economics, Politics and Business Environment
Authors: Bo Sun (Darden School of Business, University of Virginia)
Published by: Darden Business Publishing
Originally published in: 2025
Version: 26 March 2025
Length: 6 pages
Data source: Generalised experience
Topics: Biotech; Pharmaceutical; Uncertainty; Drug development; Real options; Minimax; Cost of waiting; Winner takes all; Risk; Big Pharma; Regulation; FDA; Food and Drug Administration; Generic; Biosimilar; Patent; Resources; Opportunity cost; Failure; Innovation; Venture capital; VC; Start-up; Decision framework; Government relations; Technology & innovation management; Risk management; Product development; Strategy implementation
View full details
Share a link: https://casecent.re/p/205593
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.
Supplementary software
-
Reference no. UVA-F-2028X
Subject category: Finance, Accounting and Control
Authors: Michael J Schill (Darden School of Business, University of Virginia); Adam Yates (Darden School of Business, University of Virginia)
Published by: Darden Business Publishing
Originally published in: 2023
Version: 31 October 2024
Revision date: 19-Nov-2024
Format: .xlsx
Data source: Published sources
Topics: Teva; Pharmaceuticals; Big Pharma; Multicurrency bond; Generic drug; Bond issue; M&A; Acquisition; Cross-border acquisition; Risk premium; Risk-return paradigm; Risk-free rate; Cost of debt; Default risk; Credit rating
View full details
Share a link: https://casecent.re/p/193008
| No reviews for this item
View our pricing guide or login to see prices.
Supplementary software
-
Reference no. UVA-OM-1775H3
Subject category: Production and Operations Management
Authors: Panos Markou (Darden School of Business, University of Virginia); Amy Klopfenstein (Darden School of Business, University of Virginia)
Published by: Darden Business Publishing
Originally published in: 2024
Version: 2 July 2024
Format: .pdf
Data source: Field research
Topics: Innovation; R&D; Project selection; Project portfolio decision-making; Bottom-up selection; Top-down selection; Market risk; Technology risk; Uncertainty; Pharmaceutical industry; Pharma; Big Pharma; Drug development; Cancer; Oncology
View full details
Share a link: https://casecent.re/p/199856
| No reviews for this item
View our pricing guide or login to see prices.
Supplementary software
-
Reference no. UVA-OM-1775H2
Subject category: Production and Operations Management
Authors: Panos Markou (Darden School of Business, University of Virginia); Amy Klopfenstein (Darden School of Business, University of Virginia)
Published by: Darden Business Publishing
Originally published in: 2024
Version: 2 July 2024
Format: .pdf
Data source: Field research
Topics: Innovation; R&D; Project selection; Project portfolio decision-making; Bottom-up selection; Top-down selection; Market risk; Technology risk; Uncertainty; Pharmaceutical industry; Pharma; Big Pharma; Drug development; Cancer; Oncology
View full details
Share a link: https://casecent.re/p/199855
| No reviews for this item
View our pricing guide or login to see prices.
Supplementary software
-
Reference no. UVA-OM-1775H1
Subject category: Production and Operations Management
Authors: Panos Markou (Darden School of Business, University of Virginia); Amy Klopfenstein (Darden School of Business, University of Virginia)
Published by: Darden Business Publishing
Originally published in: 2024
Version: 2 July 2024
Format: .pdf
Data source: Field research
Topics: Innovation; R&D; Project selection; Project portfolio decision-making; Bottom-up selection; Top-down selection; Market risk; Technology risk; Uncertainty; Pharmaceutical industry; Pharma; Big Pharma; Drug development; Cancer; Oncology
View full details
Share a link: https://casecent.re/p/199830
| No reviews for this item
View our pricing guide or login to see prices.
Not yet registered with us?

Register today to place orders, create search alerts, submit cases to us ... and much more.

Registered educators and trainers, and their support staff, can also access preview copies, instructor materials and see product reviews and usage.

Find out what you’re missing